Zoledronic acid to treat complex regional pain syndrome type I in adult: case report

Detalhes bibliográficos
Autor(a) principal: Castro,Anita Perpétua Carvalho de
Data de Publicação: 2011
Outros Autores: Vasconcelos,Lilian Mendes de, Nascimento,Jedson dos Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Dor
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132011000100015
Resumo: BACKGROUND AND OBJECTIVES: Complex regional pain syndrome (CRPS) is a difficult to treat disabling disease. Positive results with bisphosphonates in CRPS type I patients refractory to multimode therapy have been described. This study aimed at reporting the use of zoledronic acid in CRPS type I patient refractory to traditional therapy. CASE REPORT: Female patient, 31 years old, with CRPS for 16 years, refractory to multiprofessional and multimode treatment. Due to persistence of symptoms, zoledronic acid administration was proposed with effective control of symptoms and without adverse effects. CONCLUSION: Zoledronic acid was effective to treat CRPS type I refractory to conventional treatment.
id SBED-1_adf18d73874f04c5aa4214771aed3039
oai_identifier_str oai:scielo:S1806-00132011000100015
network_acronym_str SBED-1
network_name_str Revista Dor
repository_id_str
spelling Zoledronic acid to treat complex regional pain syndrome type I in adult: case reportBisphosphonateComplex regional pain syndromePainBACKGROUND AND OBJECTIVES: Complex regional pain syndrome (CRPS) is a difficult to treat disabling disease. Positive results with bisphosphonates in CRPS type I patients refractory to multimode therapy have been described. This study aimed at reporting the use of zoledronic acid in CRPS type I patient refractory to traditional therapy. CASE REPORT: Female patient, 31 years old, with CRPS for 16 years, refractory to multiprofessional and multimode treatment. Due to persistence of symptoms, zoledronic acid administration was proposed with effective control of symptoms and without adverse effects. CONCLUSION: Zoledronic acid was effective to treat CRPS type I refractory to conventional treatment.Sociedade Brasileira para o Estudo da Dor2011-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132011000100015Revista Dor v.12 n.1 2011reponame:Revista Dorinstname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.1590/S1806-00132011000100015info:eu-repo/semantics/openAccessCastro,Anita Perpétua Carvalho deVasconcelos,Lilian Mendes deNascimento,Jedson dos Santoseng2011-09-28T00:00:00Zoai:scielo:S1806-00132011000100015Revistahttps://www.scielo.br/j/rdor/ONGhttps://old.scielo.br/oai/scielo-oai.phpdor@dor.org.br||dor@dor.org.br2317-63931806-0013opendoar:2011-09-28T00:00Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)false
dc.title.none.fl_str_mv Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
title Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
spellingShingle Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
Castro,Anita Perpétua Carvalho de
Bisphosphonate
Complex regional pain syndrome
Pain
title_short Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
title_full Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
title_fullStr Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
title_full_unstemmed Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
title_sort Zoledronic acid to treat complex regional pain syndrome type I in adult: case report
author Castro,Anita Perpétua Carvalho de
author_facet Castro,Anita Perpétua Carvalho de
Vasconcelos,Lilian Mendes de
Nascimento,Jedson dos Santos
author_role author
author2 Vasconcelos,Lilian Mendes de
Nascimento,Jedson dos Santos
author2_role author
author
dc.contributor.author.fl_str_mv Castro,Anita Perpétua Carvalho de
Vasconcelos,Lilian Mendes de
Nascimento,Jedson dos Santos
dc.subject.por.fl_str_mv Bisphosphonate
Complex regional pain syndrome
Pain
topic Bisphosphonate
Complex regional pain syndrome
Pain
description BACKGROUND AND OBJECTIVES: Complex regional pain syndrome (CRPS) is a difficult to treat disabling disease. Positive results with bisphosphonates in CRPS type I patients refractory to multimode therapy have been described. This study aimed at reporting the use of zoledronic acid in CRPS type I patient refractory to traditional therapy. CASE REPORT: Female patient, 31 years old, with CRPS for 16 years, refractory to multiprofessional and multimode treatment. Due to persistence of symptoms, zoledronic acid administration was proposed with effective control of symptoms and without adverse effects. CONCLUSION: Zoledronic acid was effective to treat CRPS type I refractory to conventional treatment.
publishDate 2011
dc.date.none.fl_str_mv 2011-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132011000100015
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132011000100015
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1806-00132011000100015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
dc.source.none.fl_str_mv Revista Dor v.12 n.1 2011
reponame:Revista Dor
instname:Sociedade Brasileira para o Estudo da Dor (SBED)
instacron:SBED
instname_str Sociedade Brasileira para o Estudo da Dor (SBED)
instacron_str SBED
institution SBED
reponame_str Revista Dor
collection Revista Dor
repository.name.fl_str_mv Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)
repository.mail.fl_str_mv dor@dor.org.br||dor@dor.org.br
_version_ 1752126253989625856

Registros relacionados